Chromosome 11 allelotypes reflect a mechanism of chemical carcinogenesis in heterozygous p53-deficient mice

Carcinogenesis

Volumn 22, Issue 1, 2001, Pages 89-98

  Hulla, Janis E ^a,b   French, John E ^b   Dunnick, June K ^b  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 CRESIDINE; BENZENE; CARCINOGEN; PHENOLPHTHALEIN; PROTEIN P53; UNCLASSIFIED DRUG;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CARCINOMA; BREEDING; CHEMICAL CARCINOGENESIS; CHROMOSOME 11; CHROMOSOME LOSS; CHROMOSOME POLYMORPHISM; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GENE FUNCTION; GENE LOCUS; GENE LOSS; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC RECOMBINATION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; MALE; MITOSIS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SARCOMA; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; THYMUS LYMPHOMA; TOXICITY TESTING; TUMOR SUPPRESSOR GENE;

EID: 0035138551     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/22.1.89     Document Type: Article

References (40)

1. Chemical structure, Salmonella mutagenicity and extent of carcinogenecity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP
2. Organ-specific genotoxicity of the potent rodent bladder carcinogens o-anisidine and p-cresidine
3. Phenolphthalein-containing laxative use in relation to adenomatous colorectal polyps in three studies
4. Measurement of micronucleated erythrocytes and DNA damage during chronic ingestion of phenolphthalein in transgenic female mice heterozygous for the p53 gene
5. Phenolphthalein: Induction of micronucleated erythrocytes in mice
6. U.S. Food and Drug Administration laxative drug products for over-the-counter human use; proposed amendment to the tentative final rule
7. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
8. Multiple-site carcinogenicity of benzene in Fischer 344 rats and B6C3F1 mice
9. Evaluation of transgenic mouse bioassays for identifying carcinogens and noncarcinogens
10. Phenolphthalein exposure causes multiple carcinogenic effects in experimental model systems
11. Phenolphthalein induces thymic lymphomas accompanied by loss of the p53 wild type allele in heterozygous p53-deficient (+/-) mice
12. Length polymorphisms in (dC-dA)n-(dG-dT)n sequences detected using the polymerase chain reaction
13. Mouse Genetics
14. Genetic Recombination
15. Cell cycle. Piecing together the p53 puzzle
16. DNA damage-induced activation of p53 by the checkpoint kinase Chk2
17. V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors
18. Identification and cloning of E124, a gene induced by p53 in etoposide-treated cells
19. The absolute number of trans-rearrangements between the TCRG and TCRB loci is predictive of lymphoma risk: A severe combined immune deficiency (SCID) murine model
20. Mutations in the p53 and SCID genes cooperate in tumorigenesis
21. Somatic recombination, gene amplification and cancer
22. Inactivation of p53 results in high rates of homologous recombination
23. p53 directly enhances rejoining of DNA double-strand breaks with cohesive ends in gamma-irradiated mouse fibroblasts
24. Dissociation of p53-mediated suppression of homologous recombination from G1/S cell cycle checkpoint control
25. Involvement of p53 in X-ray induced intrachromosomal recombination in mice
26. Effects of DNA double-strand and single-strand breaks on intrachromosomal recombination events in cell-cycle-arrested yeast cells
27. A single gene and a pseudogene for the cellular tumour antigen p53
28. High frequency in vivo loss of heterozygosity is primarily a consequence of mitotic recombination
29. Mitotic recombination of chromosome 17 in astrocytomas
30. Tumor suppressor genes
31. Loss of heterozygosity in spontaneous and chemically induced tumors of the B6C3F1 mouse
32. Genetic background influences timing, morphology and dissemination of lymphomas in p53-deficient mice
33. Genetic background alters the spectrum of tumors that develop in p53-deficient mice
34. Effects of genetic background on tumorigenesis in p53-deficient mice
35. Stochastic modelling of tumorigenesis in p53 deficient mice